Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Safety and efficacy of colistin compared with imipenem in the treatmentof ventilator-associated pneumonia: A matched case-control study
Intensive Care Medicine, Volume 33, No. 7, Year 2007
Notification
URL copied to clipboard!
Description
Objective: Our study aimed to determine the efficacy and safety of colistin in the treatment of ventilator-associated pneumonia (VAP) caused by pan-drug-resistant Pseudomonas aeruginosa or Acinetobacter baumanii. Design: Pairwise, retrospective exposed-unexposed study. Setting: Combined medical and surgical intensive care unit of Habib Bourguiba University Hospital (Sfax, Tunisia). Patients: Sixty patients with VAP caused by pan-drug-resistant A. baumanii or P. aeruginosa matched to 60 controls with VAP caused by A. baumanii or P. aeruginosa susceptible to imipenem. All patients had normal renal function at the onset of antibiotic therapy. Interventions: Case patients were treated by colistin intravenously and control patients were treated by imipenem intravenously. Measurements and results: Baseline characteristics were similar between the colistin and imipenem groups. The mean duration of antibiotic therapy for VAP was 9.5 ± 3.8 days (range 5-22 days) with colistin and 8.9 ± 2.8 days (range 5-20 days) with imipenem (p = 0.32). A favorable clinical response to antibiotic therapy for VAP occurred in 45 patients (75%) in the colistin group and in 43 patients (71.7%) in the imipenem group (p = 0.68). The time to resolution of infectious parameters after the initiation of antibiotic therapy was not statistically different between the two groups. During the antibiotic course, none of the patients in either group developed renal failure. Conclusions: We conclude that colistin can be a safe and effective option in the treatments of VAP caused by pan-drug-resistant P. aeruginosa or A. baumanii. © 2007 Springer-Verlag.
Authors & Co-Authors
Kallel, Hatem
Tunisia, Sfax
Chu Habib Bourguiba
Hergafi, Leila
Tunisia, Sfax
Chu Habib Bourguiba
Bahloul, Mabrouk
Tunisia, Sfax
Chu Habib Bourguiba
Hakim, Ahmed
Tunisia, Sfax
Faculty of Medicine of Sfax
Dammak, Hassen
Tunisia, Sfax
Chu Habib Bourguiba
Chelly, Hédi E.
Tunisia, Sfax
Chu Habib Bourguiba
Hamida, Chokri Ben
Tunisia, Sfax
Chu Habib Bourguiba
Chaari, Adel D.
Tunisia, Sfax
Chu Habib Bourguiba
Rekik, Noureddine
Tunisia, Sfax
Chu Habib Bourguiba
Bouaziz, Mounir
Tunisia, Sfax
Chu Habib Bourguiba
Statistics
Citations: 108
Authors: 10
Affiliations: 2
Identifiers
Doi:
10.1007/s00134-007-0675-2
ISSN:
03424642
Research Areas
Health System And Policy
Study Design
Cohort Study
Case-Control Study
Study Locations
Tunisia